Published in Scand J Haematol on August 01, 1977
Evaluation of myeloid cells (tumor-associated tissue eosinophils and mast cells) infiltration in different grades of oral squamous cell carcinoma. Indian J Med Paediatr Oncol (2016) 1.39
The pathogenesis of eosinophilic endomyocardial disease in patients with carcinomas of the lung. Heart Vessels (1985) 0.97
Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report. Cancer Biol Ther (2016) 0.75
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 3.27
Sjörgren's syndrome treated with bromhexine: a randomised clinical study. Br Med J (1978) 2.96
Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis (2005) 2.14
The commonest rheumatic complaints of over six weeks' duration in a twelve-month period in a defined Swedish population. Prevalences and relationships. Scand J Rheumatol (1989) 1.85
Anti-pancreatic cellular hypersensitivity in diabetes mellitus. Diabetes (1971) 1.77
Sjögren's syndrome. A review with emphasis on immunological features. Allergy (1981) 1.74
Primary Sjögren's syndrome in patients with multiple sclerosis. Neurology (1992) 1.49
A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial. Br J Rheumatol (1995) 1.43
Treatment of collagen diseases with cytostatics. Lancet (1965) 1.36
Stem cell leukaemia in myelomatosis. Scand J Haematol (1970) 1.33
Neuropathological studies on myelomatosis. Acta Neurol Scand (1969) 1.31
Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol (2000) 1.14
[Bromhexine induced remission in a patient with Sjögren's syndrome]. Ugeskr Laeger (1977) 1.12
Acute myeloblastic leukaemia in sarcoidosis treated with methotrexate. Scand J Haematol (1980) 1.11
Effect of education, occupation and some lifestyle factors on common rheumatic complaints in a Swedish group aged 50-70 years. Ann Rheum Dis (1992) 1.03
Ca-activated ATPase activity in subcellular fractions of mouse pancreatic islets. Am J Physiol (1976) 1.03
Cell-mediated immunity in diabetes mellitus. Proc R Soc Med (1974) 1.03
Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy (1986) 1.02
Dry eyes or mouth--an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome. J Autoimmun (1989) 0.99
Mechanisms of pancreatic beta-cell destruction in type I diabetes. Diabetes Care (1989) 0.99
Treatment of prostatitis in the rat. Prostate (1984) 0.98
An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand A (1977) 0.97
Prognosis of myelomatosis on treatment with prednisone and cytostatics. Scand J Haematol (1973) 0.96
Autoimmune liver disease in patients with primary Sjögren's syndrome. J Hepatol (1994) 0.96
Unusual cases of myelomatosis. Br Med J (1971) 0.96
Sjögren's syndrome: terminology. Clin Exp Rheumatol (1996) 0.96
Anti-pancreatic, cellular hypersensitivity in diabetes mellitus. Experimental induction of anti-pancreatic, cellular hypersensitivity and associated morphological B-cell changes in the rat. Acta Allergol (1973) 0.95
HLA-D antigen frequencies in Sjögren's syndrome. Differences between the primary and secondary form. Scand J Rheumatol (1981) 0.94
Autonomic nervous symptoms in primary Sjogren's syndrome. Rheumatology (Oxford) (2008) 0.94
Auto-antibodies in Sjögren's syndrome. With special reference to liver-cell membrane antibody (LMA). Scand J Rheumatol (1979) 0.93
Antibodies to CD4 in primary Sjögren's syndrome. Rheumatology (Oxford) (2000) 0.93
Association of dry eyes and dry mouth with anti-Ro/SS-A and anti-La/SS-B autoantibodies in normal adults. Arthritis Rheum (1992) 0.93
Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol (1998) 0.93
Possible role of histamine in rheumatoid arthritis. Treatment with cimetidine and mepyramine. Allergy (1981) 0.92
Pulmonary function in patients with primary Sjögren's syndrome. Rheumatol Int (1982) 0.91
Effects of glucocorticoid on connective tissue of aorta and skin in rabbits. Biochemical studies on collagen, glycosaminoglycans, DNA and RNA. Acta Endocrinol (Copenh) (1974) 0.91
Basement membrane thickness, insulin antibodies and HLA-antigens in long standing insulin dependent diabetics with and without severe retinopathy. Diabetologia (1979) 0.90
Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone. J Rheumatol (2001) 0.90
Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes (1994) 0.89
Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome. Clin Exp Immunol (1986) 0.88
Clinical and immunological features of Sjögren's syndrome in patients with primary biliary cirrhosis with emphasis on focal sialadenitis. Acta Med Scand (1988) 0.88
Disturbances of autonomic nervous function in primary Sjögren's syndrome. Scand J Rheumatol (1997) 0.88
Autoimmune thyroiditis and primary Sjögren's syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Clin Exp Rheumatol (1991) 0.88
CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjögren's syndrome. Clin Exp Rheumatol (1996) 0.88
Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand C (1987) 0.88
Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjögren's syndrome. Scand J Rheumatol (2007) 0.87
Antibodies against nuclear components in schistosomiasis. Results compared to values in patients with rheumatoid arthritis, systemic lupus erythematosus, and osteoarthrosis. Allergy (1984) 0.87
Glucocorticoid effect on repair processes in vascular connective tissue. Morphological examination and biochemical studies on collagen RNA and DNA in rabbit aorta. Acta Endocrinol (Copenh) (1975) 0.87
On the late effects of removal of the normal spleen. A follow-up study of 40 persons. Acta Chir Scand (1967) 0.86
Autoimmune insulitis. Pathological findings in experimental animal models and juvenile diabetes mellitus. Acta Endocrinol Suppl (Copenh) (1976) 0.86
Revisiting Sjögren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK. Rheumatology (Oxford) (2001) 0.86
Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients. J Intern Med (1999) 0.86
Sympathetic dysfunction in patients with primary Sjögren's syndrome. J Rheumatol (2001) 0.86
Bromhexine treatment of Sjögren's syndrome: effect on lacrimal and salivary secretion, and on proteins in tear fluid and saliva. Scand J Rheumatol (1981) 0.86
Antibodies to SS-B in chronic inflammatory connective tissue diseases. Relationship with HLA-Dw2 and HLA-Dw3 antigens in primary Sjögren's syndrome. Arthritis Rheum (1982) 0.85
Disturbances of autonomic nervous function in primary Sjögren's syndrome. Scand J Rheumatol (1997) 0.85
Pulmonary function in patients with rheumatoid arthritis. Scand J Rheumatol (1982) 0.84
The fate of corpuscular antigen in leukocyte migration cultures. Transplant Proc (1972) 0.84
Correlation of fatty acid composition of adipose tissue lipids and serum phosphatidylcholine and serum concentrations of micronutrients with disease duration in rheumatoid arthritis. Ann Rheum Dis (1990) 0.84
Seroprevalence of Helicobacter pylori in primary Sjögren's syndrome. Clin Exp Rheumatol (2002) 0.84
Editorial comments to the four sets of criteria for Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 0.84
Enhanced DNA damage-induced p53 peptide phosphorylation and cell-cycle arrest in Sjögren's syndrome cells. Eur J Clin Invest (2002) 0.84
Patients with primary Sjögren's syndrome treated for two months with evening primrose oil. Scand J Rheumatol (1986) 0.84
Alkeran (Melphalan) in the treatment of myelomatosis. Acta Med Scand Suppl (1966) 0.84
The effect of dynamic strength back exercise and/or a home training program in 57-year-old women with chronic low back pain. Results of a prospective randomized study with a 3-year follow-up period. Spine (Phila Pa 1976) (1997) 0.83
Pseudothrombocytopenia. In vitro studies on the underlying mechanism. Scand J Haematol (1981) 0.83
Two additional cases of coexisting polycythaemia vera and chronic lymphocytic leukaemia. Scand J Haematol (1982) 0.83
Anti-ENA antibody in serum determined by ELISA-technique. Description of method and recommended procedure. Allergy (1981) 0.83
Salivary gland scintigraphy in subjects with and without symptoms of dry mouth and/or eyes, and in patients with primary Sjögren's syndrome. Scand J Rheumatol (1994) 0.82
The ultrastructure of the acini of the human lacrimal gland. Acta Ophthalmol (Copenh) (1969) 0.82
Fibrosis regression induced by intravenous gammaglobulin treatment. Ann Rheum Dis (2003) 0.82
Salivary gland involvement in autoimmune thyroiditis, with special reference to the degree of association with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol (1992) 0.82
Immunoglobulin deposits in the epidermis of patients with primary Sjögren's syndrome. A consecutive study. Rheumatol Int (1984) 0.81
Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome. Arthritis Rheum (1986) 0.81
Estimation of pulmonary diffusion resistance and shunt in an oxygen status model. Comput Methods Programs Biomed (1996) 0.81
Lewis blood type frequency in patients with primary Sjögren's syndrome. A prospective study including analyses for A1A2BO, Secretor, MNSs, P, Duffy, Kell, Lutheran and rhesus blood groups. Scand J Rheumatol (1985) 0.81
The diagnostic accuracy of the frozen section examination in neurosurgery. Acta Neurol Scand (1966) 0.81
Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 0.80
Splenectomy in chronic lymphocytic leukaemia. Scand J Haematol (1977) 0.80
Definition and criteria for Sjögren's syndrome used by the contributors to the First International Seminar on Sjögren's syndrome--1986. Scand J Rheumatol Suppl (1986) 0.80
The clinical significance of insulin antibodies. Acta Paediatr Scand Suppl (1977) 0.80
Detection of antibody against extractable nuclear antigen by an enzyme-linked immuno-sorbent assay. Results from patients with rheumatic and internal medical diseases. Allergy (1985) 0.80
Morphologic investigations on the leucocyte migration test (LMT). Scand J Immunol (1972) 0.79
The ultrastructure of eosinophilic granulocytes in the peritoneal cavity of rats following injection of ferritin. Scand J Haematol (1966) 0.79
Anti-DNA antibody in serum measured by radioimmunoassay (Farr technique). Description of method and recommended procedure. Allergy (1978) 0.79
Megathrombocytopenia associated with glomerulonephritis, deafness and aortic cystic medianecrosis. Scand J Haematol (1978) 0.79
A human IgA-myeloma protein with anti-streptococcal hyaluronidase (ASH) activity. Scand J Haematol (1973) 0.79
Direct streptozotocin toxicity on dispersed mouse islet cells determined by [51]Cr-release. Med Biol (1980) 0.79
Congenital complete heart block in children of mothers with primary Sjögren's syndrome. Lancet (1992) 0.79
Jaccoud's syndrome. A nosographic entity associated with systemic lupus erythematosus. J Rheumatol (1980) 0.79
Treatment of immunologic diseases with cytostatics. Acta Med Scand (1969) 0.78
The absence of evidence suggesting that systemic lupus erythematosus is a zoonosis of dogs. Vet Rec (1979) 0.78
Splenectomy in haematology. Indications, results, and complications in 41 cases. Scand J Haematol (1970) 0.78
Smell and nasal findings in patients with primary Sjögren's syndrome. Scand J Rheumatol Suppl (1986) 0.78
Quantitation of complement C3b and C3d surface receptors on neoplastic IgM positive B lymphocytes. Acta Pathol Microbiol Scand C (1981) 0.78
Immunohistochemistry of the B-cell component in lower lip salivary glands of Sjögren's syndrome and healthy subjects. Scand J Immunol (2005) 0.78
Clinical assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol (1979) 0.78
Anti-pancreatic, cellular hypersensitivity in diabetes mellitus. Antigenic activity of fetal calf pancreas and correlation with clinical type of diabetes. Acta Allergol (1973) 0.77
Glucose intolerance and islet damage in mice immunized with homologous endocrine pancreas--a preliminary communication. Horm Metab Res (1974) 0.77